Background-Loss of transient outward K + current (I to ) is well documented in cardiac hypertrophy and failure both in animal models and in humans. Electrical remodeling contributes to prolonged action potential duration and increased incidence of arrhythmias. Furthermore, there is a growing body of evidence linking microRNA (miR) dysregulation to the progression of both conditions. In this study, we examined the mechanistic basis underlying miR dysregulation in electrical remodeling and revealed a novel interaction with the adrenergic signaling pathway. Methods and Results-We first used a tissue-specific knockout model of Dicer1 in cardiomyocytes to reveal the overall regulatory effect of miRs on the ionic currents and action potentials. We then validated the inducible cAMP early repressor as a target of miR-1 and took advantage of a clinically relevant model of post myocardial infarction and miR delivery to probe the mechanistic basis of miR dysregulation in electrical remodeling. These experiments revealed the role of inducible cAMP early repressor as a repressor of miR-1 and I to , leading to prolonged action potential duration post myocardial infarction. In addition, delivery of miR-1 and miR-133a suppressed inducible cAMP early repressor expression and prevented both electrical remodeling and hypertrophy. Conclusions-Taken together, our results illuminate the mechanistic links between miRs, adrenergic signaling, and electrical remodeling. They also serve as a proof-of-concept for the therapeutic potential of miR delivery post myocardial infarction. (Circ Arrhythm Electrophysiol. 2015;8:942-950.
M icroRNAs (miRs) are endogenously expressed, noncoding RNAs of ≈22 nucleotides in length. 1 When processed by the ribonuclease III (RNase III) enzyme, DICER1, and incorporated into the RNA-induced silencing complex, they target a variety of coding messenger RNAs for degradation and translational repression. 2 In cardiac hypertrophy and failure, the cardiomyocyte-specific miR-1 and miR-133a are dramatically reduced. 3, 4 These miRs are cotranscribed from a common gene and together have been ascribed critical regulatory roles in hypertrophy, 3, 5, 6 apoptosis, 7, 8 fibrosis, 9 and ion channel expression. [10] [11] [12] [13] [14] MiR-1, in particular, has been shown to enhance the transient outward K + current (I to ) by repressing iroquois homeobox domain 5 (IRX5), a transcriptional inhibitor of K v 4.2 (Kcnd2), the main pore-forming subunit for I to , and loss of miR-1 may underlie the I to remodeling seen post myocardial infarction (MI). 12, 15, 16 In the acute phase of MI, levels of miR-1 and miR-133a increase and can be detected in the circulation. 17 However, these miRs quickly decline, 18, 19 and lead to chronically depressed levels. 20 Myocardia from patients with ischemic heart failure exhibited decreased levels of miR-1 and miR-133a, which were restored after implantation of a left ventricular assist device. 21 In a separate study, loss of DICER1 reported in the end-stage heart failure patients was similarly rescued by left ventricular assist device implantation. 22 A recent study has identified the presence of a cAMP response element (CRE) sequence in the miR-1/miR-133a promoter region, 23 implicating a potential role for β-adrenergic signaling in the regulation of miR expression. In addition, CRE modulator (CREM) is a predicted target of miR-1. CREM acts as a regulator of CRE-binding protein (CREB) signaling. 24 Both the proteins are activated by β-adrenergic signaling and compete for binding to the CRE in gene promoters. 25, 26 One isoform of CREM, termed the inducible cAMP early repressor (ICER), arises from an alternative internal promoter and is induced by β-adrenergic signaling. 27 ICER contains only the CRE DNA-binding domain and acts as a powerful repressor of CREB signaling. Under physiological conditions, ICER acts in a negative feedback fashion to prevent over activation of CREB-dependent genes. Under chronic pathological conditions, excessive β-adrenergic signaling drives a progressive increase in ICER expression that may contribute to inhibition of CREB-dependent gene expression and β-adrenergic desensitization. 28, 29 Recent studies have documented the beneficial effects of preserving β-adrenergic sensitivity after an MI 30, 31 and knockout of CREM was shown to be protective under chronic β-adrenergic signaling. 32 In addition, cardiac-specific knockout of CREB led to electrical remodeling in cardiomyocytes similar to that seen post MI with a loss of I to and prolonged action potential durations (APDs). 33 Electrical remodeling has been well documented in cardiac hypertrophy and failure with downregulation of K + currents and APD prolongation. 34 Moreover, recent studies have provided strong evidence for the critical roles of miRs in ion channel regulation. [10] [11] [12] [13] [14] In addition, loss of miRs may underlie the well-documented electrical remodeling seen in pathological cardiac hypertrophy and failure. 12, 15, 16 However, the mechanistic basis leading to miRs dysregulation with significant loss of miR-1/miR-133a in diseased conditions remains incompletely understood.
Because the promoter region of cardiac-specific miR-1/ miR-133a contains the CRE sequence, we hypothesize that chronic cAMP signaling may underlie miRs dysregulation. Specifically, we hypothesize that under pathological conditions, chronic overexpression of ICER from excessive β-adrenergic signaling 28,29 may repress miR-1 expression leading to the well-documented electrical remodeling. To test the hypothesis, we first examined the roles of miRs in the regulation of cardiac excitability by taking advantage of a knockout model of Dicer1 and cardiac delivery of Cre recombinase. This model allowed us to directly test the roles of miRs on ionic currents without the interference of organ level changes, such as hypertrophy or fibrosis. We then investigated the relationship between miR-1/miR-133a, cAMP signaling, and electrical remodeling in a clinically relevant mouse model of MI. Indeed, we documented that Icer mRNA is significantly increased in the MI model. We further demonstrated that chronic isoproterenol infusion results in similar upregulation of Icer mRNA. In vivo delivery of miRs was used to directly establish the relationship between miR-1/miR-133a and ICER. Expression of ICER is normalized after delivery of miRs in both the MI and the chronic isoproterenol infusion models. Moreover, we directly validate both CREM and ICER as the targets of miR-1 establishing a feedback mechanism between cardiac-specific miRs and cAMP signaling. Our study uncovers novel mechanisms of interactions between cardiac-specific miRs, pathological cAMP signaling post MI, and their possible roles in proarrhythmic electrical remodeling.
Methods
Detailed Materials and Methods are available in the Data Supplement. All animal care and procedures were approved by the University of California, Davis, Institutional Animal Care and Use Committee. Animal care and use were in accordance with National Institutes of Health and institutional guidelines.
Neonatal Mouse Cardiomyocyte Culture
Cardiomyocytes from 1 to 3 days old neonatal Dicer1 tm1Bdh /J were isolated by enzymatic digestion using trypsin as described in the Data Supplement.
Intramyocardial Adenovirus Injection
C57 BL/6J and Dicer1 tm1Bdh /J mice (8-12 weeks) were anesthetized. Recombinant adenovirus (50-100 μL) containing Cre recombinase (Cre) and green fluorescence protein (GFP; Ad-GFP-Cre) was delivered via intramyocardial injection to the left ventricular-free wall. Cardiomyocytes were isolated 2 weeks after the injection. Transduced cells were identified based on GFP fluorescence. Dicer1 tm1Bdh /J mice injected with Ad-GFP served as additional controls.
MI Mouse Model
Ischemia-reperfusion (IR) model of MI was performed as previously published. [35] [36] [37] C57 BL/6J mice (10-16 weeks) were prepared and the heart exposed to reveal the left anterior descending coronary artery. The left anterior descending coronary artery was then ligated for 45 minutes and allowed to reperfuse.
In Vivo miR Injections
Mmu-miR-1 and miR-133a mimics (Dharmacon C-310377, C-310408) were packaged as using MaxSuppressor in vivo RNA-LANCEr II (Bioo scientific 3410-01) and delivered together via tail vein injections 1 week after left anterior descending coronary artery surgery at 30 μg per 28 g mouse. Nonsilencing MiR mimic transfection control with and without Dy547 (Dharmacon CP-004500-01) was injected in control animals.
In Vivo Mouse Model of Isoproterenol Infusion
In vivo isoproterenol infusion at a dose of 30 mg/kg per day in C57 BL/6J mice (10-16 weeks) was performed using Alzet osmotic
WHAT IS KNOWN
• Electrical remodeling is well documented in cardiac hypertrophy and failure both in animal models and in humans, contributing to prolonged action potential duration and increased incidence of arrhythmias.
• Even though cardiomyocyte-specific miR-1 and miR-133a have been documented to be dramatically reduced in cardiac hypertrophy and failure, the underlying mechanisms for the miR dysregulation remain incompletely understood.
WHAT THE STUDY ADDS
• Expression of the inducible cAMP early repressor is significantly increased in animal models post myocardial infarction or chronic isoproterenol infusion leading to long-term suppression of miR-1 and miR-133a.
• Furthermore, both cAMP response element modulator and inducible cAMP early repressor are targets of miR-1 and delivery of miR-1 and miR-133a suppressed inducible cAMP early repressor expression and prevented both electrical remodeling and hypertrophy.
• Our study establishes a feedback mechanism between cardiac-specific miRs, adrenergic signaling, and electrical remodeling. They also serve as a proof-of-concept for the therapeutic potential of miR delivery post myocardial infarction. mini-pumps for 6 hours, 2, 4, and 14 days. 38 Sham littermate animals received osmotic mini-pumps loaded with saline alone.
Analysis of Cardiac Function by Echocardiography
Echocardiograms using M-mode and 2-dimensional measurements to assess systolic function were performed as described previously. 37 
Electrocardiographic Recordings
Electrocardiographic recordings were obtained at 33°C using Bioamplifier (BMA 831, CWE, Incorporated, Ardmore, PA) as previously described. 39 A total of 100 beats were analyzed from each animal in a blinded fashion. The rate-corrected QT interval (QT c ) was calculated using modified Bazett formula as reported by Mitchell et al 40 for mouse models, whereby the R-R interval was first expressed as a unitless ratio (R-R in ms/100 ms). QT c interval was defined as (QT interval [in ms]/[RR/100] 1/2 ).
Adult Mouse Cardiomyocyte Isolation
Single mouse left ventricular myocytes were isolated as previously described. 41 The cells were then enriched for cardiomyocytes. Final cell populations were determined to be 95% myocytes as measured by flow cytometry ( Figure I in the Data Supplement).
Patch-Clamp Recordings
Whole cell and perforated patch clamp recordings were performed as previously described. 41, 42 
Flow Cytometric Analysis
Flow cytometric analysis of isolated mouse cells was performed as described. 37
Quantitative Real-Time Polymerase Chain Reaction
RNA was isolated from adherent neonatal and dissociated adult cardiomyocytes. Quantitative real-time polymerase chain reaction was performed using RT 2 SYBR Green Master Mix (Qiagen 330520) and the Viia 7 Real-Time polymerase chain reaction System (ABI).
Immunofluorescence Confocal Microscopy
Immunofluorescence confocal microscopy was performed as previously described. 43, 44 
miR-1 Target Validation Using Luciferase Assay and Western Blot Analysis
Luciferase assay was performed using the Dual-Light Luciferase and β-Galactosidase Reporter Gene Assay System (Life Technologies T1003). Additional validation was performed using Western blot analysis.
Statistical Analyses
Significant difference between groups was determined using Origin Pro 7 software by 1-way ANOVA and validated by Bonferroni, Sheffe, and Tukey tests with an n>3 at P<0.05 unless otherwise noted.
Results

A Loss of DICER1 Results in Electrical Remodeling Independent of Cardiac Hypertrophy and Failure
Mouse hearts subjected to IR displayed decreased levels of Dicer1 mRNA ( Figure 1A ). To directly determine if a loss of DICER1 alone without concomitant cardiac hypertrophy can result in electrical remodeling of cardiac ionic currents and action potentials, Cardiomyocytes which were transduced with Ad-GFP-Cre were identified using GFP fluorescence. Bottom, The summary data of action potential duration (APD) at 50% and 90% of repolarization (APD 50 and APD 90 , n=8 for each group, *P<0.05). D, Examples of I to recorded from left ventricular myocytes isolated from WT and Dicer flx/flx mice. I to was elicited from a holding potential of −80 mV using a family of voltage steps from −70 to +60 mV with 10-mV increment and 2.5 s in duration. The interpulse interval was 10 s. Bottom, The summary data for the current-voltage relationships for the peak and steady-state currents (n=7 for each groups, *P<0.05). E, Examples of I Ca recorded from left ventricular myocytes isolated from adult WT and Dicer flx/flx mice. I Ca was elicited from a holding potential of −55 mV using a family of voltage steps from −40 to +60 mV with 10-mV increment and 500 ms in duration. The interpulse interval was 5 s. Bottom, The summary data for the current-voltage relationships (n=5 for WT and 10 for Dicer flx/flx mice, respectively, *P<0.05).
we delivered a Cre recombinase expressing adenovirus (Ad-GFP-Cre) to the left ventricles of Dicer1 tm1Bdh /J mice ( Figure 1B ) that contain a floxed RNase III domain critical for DICER1 function. 45 This model allowed us to directly test the roles of miRs on ionic currents without the interference of organ level changes, such as hypertrophy or fibrosis. Patch-clamp analyses were performed using isolated ventricular myocytes. Knockout of Dicer1 in adult mouse cardiomyocytes led to prolonged APDs ( Figure 1C ) resulting from decreased transient outward K + current (I to ; Figure 1D ) and increased Ca 2+ currents (I Ca ; Figure 1E ).
Parallel experiments were performed using cardiomyocytes isolated from neonatal Dicer1 tm1Bdh /J mice. Cells were transduced 48 hours after isolation with Ad-GFP-Cre or Ad-GFP for experimental and control groups, respectively, at a multiplicity of infection of 10 to 50. Myocytes were cultured for a total of 7 days and subjected to patch-clamp recording of I to currents and real-time polymerase chain reaction analyses. Figure 2A shows immunofluorescence confocal images of neonatal cardiomyocytes transduced with Ad-GFP and Ad-GFP-Cre. Cre recombinase (red) can be detected in the nuclei of Ad-GFP-Cre cells. Furthermore, reverse transcription polymerase chain reaction products show expression of Cre transcripts in Ad-GFP-Cre transfected cells ( Figure 2B ). Knockout of Dicer resulted in increased and decreased transcripts for Ca v 1.2 (Cacna1c) and K v 4.2 (Kcnd2), respectively ( Figure 2C ). Patch-clamp analyses further demonstrated a significant downregulation of I to ( Figure 2D) in Dicer knockout cardiomyocytes. Moreover, there was a significant increase in the expression of the known Kcnd2 transcriptional inhibitor, IRX5, a validated target of miR-1 12, 15, 16 (Figure 2c ).
Crem and Icer are Targets of miR-1
Using microRNA.org and miRwalk databases, we identified CREM, as well as its 2 ICER isoforms, as potential targets of miR-1 with an mirSVR score of −1.2211. To directly validate CREM and ICER as miR-1 targets, we first identified the predicted miR-1 binding sequence to be present in the 3′ untranslated regions of all CREM isoforms except CREM7 and 8, which correspond to τ-like isoforms not found in the heart 46 (Figure 3A) . Importantly, the miR-1 binding sequence was found in the 2 ICER isoforms of CREM ( Figure 3A ). The conserved sequence (Crem) and scramble sequence (scramble) were subcloned into luciferase reporter vectors ( Figure IIa in the Data Supplement). Luciferase assays were then performed using a miR-1 mimic compared with a nonsilencing control miR. A vector expressing β-galactosidase served as a loading control for normalization. MiR-1 treatment induced a dose-dependent decrease in luminescence in the Crem-transfected cells ( Figure IIb and IIc in the Data Supplement). Crem-transfected cells displayed a 23% decrease in luminescence with miR-1 treatment (1 pmol) compared with the control miR ( Figure 3B and 3C). No change from control was observed with miR-1 treatment in cells transfected with the scramble sequence or empty vector.
We further validated CREM and ICER as miR-1 targets at the protein level using Western blot analysis ( Figure IId in the Data Supplement). HEK 293 cells were transfected with a plasmid containing human Crem. Cells were then treated with miR-1 mimic and compared with a nonsilencing control miR. Western blot analysis was performed using anti-CREM and anti-β-tubulin antibodies demonstrating a significant reduction in the level of 
Delivery of miR-1/133a Preserves Left Ventricular Function and Prevents Hypertrophy After MI
We took advantage of in vivo delivery of miR-1 and the cotranscribed miR-133a to directly test the roles of miR-1 and miR-133 on the long-term electrical remodeling after an MI. The optimization of miR-1/miR-133a delivery was first performed in HEK 293 cells ( Figure III in the Data Supplement). We used a clinically relevant model of IR in wild-type C57 mice where the left ascending coronary artery was ligated for 45 minutes and then allowed to reperfuse ( Figure IVa in the Data Supplement). We reason that this model accurately represents the clinical situation where occluded coronary arteries are rapidly revascularized. In both the IR model and in patients, the long-term effects of MI include hypertrophy, fibrosis, electrical remodeling, and progression toward heart failure.
Echocardiographic recordings 1 week after IR surgery revealed decreased fractional shortening and increased left ventricular end-systolic diameter ( Figures 4C; Figure IVb in the Data Supplement). Mice were then randomized to receive miR-1 and miR-133a or control nonsilencing miR packaged in a neutral lipid emulsion by tail vein injections ( Figure 4A and 4B). Three weeks after IR surgery, fractional shortening continued to decline in MI mice receiving the control injection (MI control), whereas MI mice that received the miR-1/miR-133a injection (MI+miRs) displayed a significant improvement in fractional shortening (*P<0.05; Figures 4C; Figure  IV in the Data Supplement). MI control mice also exhibited increased heart weight/body weight ratio ( Figure 4D ) and demonstrated increased transcripts of atrial natriuretic peptide (Nppa) and angiotensinogen (Agt; Figure 4D ). In all cases, hypertrophy was prevented in the MI miR mice ( Figure 4D , heart weight/body weight ratio) and levels for Nppa and Agt returned to the sham levels ( Figure 4D ). Angiotensinogen is a predicted target of miR-133a and local release of angiotensinogen has been described as pathological in MI. 47 Nppa and skeletal α-actin (Acta1) are not predicted targets of miR-1 nor miR-133a but their expression has been linked to both miRs through indirect mechanisms. 6, 9 
Delivery of miR-1/miR-133a Prevents Electrical Remodeling After MI
To directly test the roles of miR-1 and miR-133a on electrical remodeling, we performed patch-clamp recordings of I to , I Ca , and APD on isolated cardiomyocytes. In MI mice, peak I to current was significantly reduced ( Figure 5A ), leading to prolonged APD ( Figure 5B ). Moreover, delivery of miR-1 and miR-133a resulted in the recovery of peak I to density toward the sham levels ( Figure 5A ) together with normalization of the 
Figure 5. miR-1/133a
Delivery prevents I to remodeling action potential duration (APD) prolongation after myocardial infarction (MI). A, Representative I to traces from sham and MI mice after tail vein injection of miR-1/133 mimics or control miR using the same voltageclamp protocol as in Figure 1 . Bottom, The summary data for the peak and steady-state current-voltage relationships (n=9-11 for each group, *P<0.05). B, Representative AP recordings of sham and MI mice after tail vein injection of miR-1/133 mimics or control miR. Bottom, The summary data for APD 50 and APD 90 (n=6-8 for each group, *P<0.05).
voltage-dependent activation of I to toward sham control (Figure V in the Data Supplement; *P<0.05). Indeed, after MI, there were a 35% decrease in K v 4.2 channel transcripts (Kcnd2) and a 77% increase in Irx5 ( Figure 6A ). MiR-1/133a delivery prevented the increase in Irx5 expression and increased Kcnd2 levels to 85% of sham levels ( Figure 6A ). In addition, consistent with the findings observed after Dicer knockout (Figure 1E) , peak I Ca density ( Figure VI in the Data Supplement) elicited at +10 mV was significantly reduced by miR delivery.
ICER is Increased in MI and Chronic Isoproterenol Infusion Models and the Expression of ICER is Normalized After the Delivery of miRs in Both Models
Using a primer specific to ICER isoforms, we found that Icer mRNA increased >2-fold in MI control mice, consistent with previous studies, which demonstrate that Icer can be activated by β-adrenergic signaling. 25, 26 More importantly, the level of Icer returned to the sham levels with miR delivery ( Figure 6B ). Using a primer that recognizes all isoforms of Crem except for Icer, we found that non-Icer Crem mRNA did not increase in MI control but that miR delivery decreased the expression by 60% in both sham+miR and MI+miR mice. Creb expression decreased slightly with MI but was not affected by miR delivery.
To directly test the roles of β-adrenergic signaling on the expression of ICER and miRs in the heart, we took advantage of the second mouse model with chronic isoproterenol infusion. Transcript levels of Icer, Creb, Kcnd2, miR-1, and miR-133 were assessed from cardiac myocytes ( Figure VIIa 
Discussion
Even though significant loss of miRs has previously been documented in pathological cardiac hypertrophy and failure, 12, 15, 16 the underlying mechanisms for the miR dysregulation remain incompletely understood. This study directly tests the hypothesis that chronic overexpression of ICER from excessive β-adrenergic signaling 28,29 may repress miR-1 expression leading to the well-documented electrical remodeling. First, by taking advantage of a knockout model of Dicer1 in the heart, we demonstrated the direct regulation of cardiac excitability by miRs. We further confirmed that miR-1 directly targets and represses the expression of CREM and ICER. The level of ICER expression is increased during pathological conditions, such as post MI. Moreover, chronic isoproterenol stimulation induces a similar increase in ICER expression supporting the roles of β-adrenergic stimulation in the upregulation of ICER. By using in vivo delivery of miRs, we directly establish the relationship between miR-1/133a and the expression of ICER. Finally, our study provides a tantalizing proof-of-concept for the therapeutic potential of miR delivery post MI.
Possible Feedback Mechanism Between miR-1/133a, CREs, and Electrical Remodeling
In the post MI model, chronic β-adrenergic stimulation is predicted to result in the overexpression of ICER, which leads to long-term suppression of miR-1 and miR-133a. Indeed, using a chronic isoproterenol infusion, we directly document a significant increase in ICER expression by β-adrenergic stimulation. A decrease in miR-1 leads to a further increase in ICER level. Moreover, exogenous delivery of miR-1 results in the normalization of ICER levels in both models ( Figure 6B Loss of miR-1 leads to overexpression of IRX5, loss of K v 4.2 and I to , and prolonged APDs. Loss of miR-133a leads to increased angiotensinogen expression and hypertrophy. Indeed, the delivery of cardiac-specific miRs can restore the level of ICER toward the control. Taken together, the results in our study suggest a feedback mechanism between miR-1/133a, CREs, and electrical remodeling in pathological conditions with heightened βAR stimulation ( Figure 6C ).
Roles of CREM and ICER in the Heart
Consistent with our hypothesis, recent studies have shown that prevention of β-adrenergic desensitization after an MI can improve ejection fraction and survivability while decreasing cardiac hypertrophy and apoptosis. 30, 31 It has been demonstrated that cardiacspecific knockout of CREM prevented hypertrophy, fibrosis, and LV dysfunction associated with chronic β-adrenergic signaling. 32 Conversely, cardiac-driven ICER and CREM overexpression led to increased apoptosis and progressive mortality. 48 Moreover, cardiac-specific knockout of CREB led to a 50% reduction in K v 4.2 resulting in a significant loss of peak I to and prolonged APDs even though the K v 4.2 promoter seems to lack a CRE sequence. 33 Our findings demonstrating that both CREM and ICER are direct targets of miR-1 may help explain these earlier results. Moreover, increased expression of ICER post MI leads to a reduction of miR-1 and miR-133 and the consequences of electrical remodeling.
Knockout of Dicer1 driven by the α-myosin heavy chain promoter has been shown to result in increased mortality, hypertrophy, dilated cardiomyopathy, increased fibrosis and apoptosis, and remodeling of gap junction proteins. 12, 22 The mechanism of DICER1 loss seen in heart failure and post MI remains elusive, although evidence suggests it may be a response to stresses in failing hearts, which are relieved by the left ventricular assist devices. Further evidence of a stressdependent mechanism come from experiments in culture that show a loss of Dicer expression in a variety of cell types in response to treatment with reactive-oxygenated species via H 2 O 2 , interferons, or serum withdrawal. 49, 50 
Clinical Implications and Future Studies
Electrical remodeling in cardiac hypertrophy and failure can predispose patients to malignant arrhythmias and sudden cardiac death. Our study reveals novel mechanisms underlying electrical remodeling via the dysregulation of miRs and implicates ICER as a potential therapeutic target. At the translational level, our study provides a molecular basis for the potential roles for miR-1 and miR-133a therapy post MI and offers a proof-of-concept for miR intervention. Future studies are required to further dissect and quantify the beneficial effects of miR delivery on cardiac remodeling, including the degree of cardiac fibrosis and apoptosis.
In this study, miR delivery was performed 1 week post MI. However, at 3 weeks of follow-up, ICER level remains elevated in the MI control group ( Figure 6B ). Therefore, we expect miR delivery to reduce ICER level and possibly prevent further remodeling and provide beneficial outcomes. Nonetheless, additional studies are required to test whether this strategy may be applicable to pre-existing MI with substantial remodeling as well as the long-term beneficial effects of miR intervention.
